Establishment and characterization of a novel ALL-L3 cell line (BALM- 18): Induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells

Yoshinobu Matsuo, Akira Sugimoto, Akira Harashima, Chiharu Nishizaki, Fumihiko Ishimaru, Eisei Kondo, Yoshio Katayama, Mine Harada, Kunzo Orita

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A human acute lymphoblastic leukemia (ALL) cell line, BALM-18, was established from the peripheral blood specimen of a patient with B cell ALL L3 type (ALL-L3) at diagnosis using bone marrow stroma cells (BST) as feeder cells. The primary leukemia cells did not grow without feeder cells. As with the primary leukemia cells, BALM-18 showed an immunophenotype of Burkitt's lymphoma group I [CD10 +, CD20 +, CD23-, CD39-, CD77+] and carried the t(8;14)(q24;q32) chromosomal abnormality which is highly associated with ALL- L3 and Burkitt's lymphoma. It also revealed a significantly low level of bcl- 2 protein. Strikingly, anti-human IgM antibody did induce apoptosis in induction experiments. However, it was reversed by the addition of anti-CD40 antibody or BST cells, whereas the culture supernatant of the stroma cells did not show any effect on the inhibition of apoptosis. BALM-18 may be useful for analyzing both the mechanisms of anti-IgM induced apoptosis and signaling during the inhibition of apoptosis by CD40 or BST cells.

Original languageEnglish
Pages (from-to)559-568
Number of pages10
JournalLeukemia Research
Volume23
Issue number6
DOIs
Publication statusPublished - Jun 1999

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Bone Marrow Cells
Apoptosis
Feeder Cells
Cell Line
Burkitt Lymphoma
Leukemia
Chromosome Aberrations
Anti-Idiotypic Antibodies
B-Lymphocytes
Cell Culture Techniques
anti-IgM
Antibodies
Proteins

Keywords

  • ALL-L3
  • Anti-IgM
  • Apoptosis
  • Bone marrow stroma cells
  • CD40
  • Cell line

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Establishment and characterization of a novel ALL-L3 cell line (BALM- 18) : Induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells. / Matsuo, Yoshinobu; Sugimoto, Akira; Harashima, Akira; Nishizaki, Chiharu; Ishimaru, Fumihiko; Kondo, Eisei; Katayama, Yoshio; Harada, Mine; Orita, Kunzo.

In: Leukemia Research, Vol. 23, No. 6, 06.1999, p. 559-568.

Research output: Contribution to journalArticle

Matsuo, Yoshinobu ; Sugimoto, Akira ; Harashima, Akira ; Nishizaki, Chiharu ; Ishimaru, Fumihiko ; Kondo, Eisei ; Katayama, Yoshio ; Harada, Mine ; Orita, Kunzo. / Establishment and characterization of a novel ALL-L3 cell line (BALM- 18) : Induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells. In: Leukemia Research. 1999 ; Vol. 23, No. 6. pp. 559-568.
@article{4c4ffa7805ea4c809293e549c17ac719,
title = "Establishment and characterization of a novel ALL-L3 cell line (BALM- 18): Induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells",
abstract = "A human acute lymphoblastic leukemia (ALL) cell line, BALM-18, was established from the peripheral blood specimen of a patient with B cell ALL L3 type (ALL-L3) at diagnosis using bone marrow stroma cells (BST) as feeder cells. The primary leukemia cells did not grow without feeder cells. As with the primary leukemia cells, BALM-18 showed an immunophenotype of Burkitt's lymphoma group I [CD10 +, CD20 +, CD23-, CD39-, CD77+] and carried the t(8;14)(q24;q32) chromosomal abnormality which is highly associated with ALL- L3 and Burkitt's lymphoma. It also revealed a significantly low level of bcl- 2 protein. Strikingly, anti-human IgM antibody did induce apoptosis in induction experiments. However, it was reversed by the addition of anti-CD40 antibody or BST cells, whereas the culture supernatant of the stroma cells did not show any effect on the inhibition of apoptosis. BALM-18 may be useful for analyzing both the mechanisms of anti-IgM induced apoptosis and signaling during the inhibition of apoptosis by CD40 or BST cells.",
keywords = "ALL-L3, Anti-IgM, Apoptosis, Bone marrow stroma cells, CD40, Cell line",
author = "Yoshinobu Matsuo and Akira Sugimoto and Akira Harashima and Chiharu Nishizaki and Fumihiko Ishimaru and Eisei Kondo and Yoshio Katayama and Mine Harada and Kunzo Orita",
year = "1999",
month = "6",
doi = "10.1016/S0145-2126(99)00046-6",
language = "English",
volume = "23",
pages = "559--568",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Establishment and characterization of a novel ALL-L3 cell line (BALM- 18)

T2 - Induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells

AU - Matsuo, Yoshinobu

AU - Sugimoto, Akira

AU - Harashima, Akira

AU - Nishizaki, Chiharu

AU - Ishimaru, Fumihiko

AU - Kondo, Eisei

AU - Katayama, Yoshio

AU - Harada, Mine

AU - Orita, Kunzo

PY - 1999/6

Y1 - 1999/6

N2 - A human acute lymphoblastic leukemia (ALL) cell line, BALM-18, was established from the peripheral blood specimen of a patient with B cell ALL L3 type (ALL-L3) at diagnosis using bone marrow stroma cells (BST) as feeder cells. The primary leukemia cells did not grow without feeder cells. As with the primary leukemia cells, BALM-18 showed an immunophenotype of Burkitt's lymphoma group I [CD10 +, CD20 +, CD23-, CD39-, CD77+] and carried the t(8;14)(q24;q32) chromosomal abnormality which is highly associated with ALL- L3 and Burkitt's lymphoma. It also revealed a significantly low level of bcl- 2 protein. Strikingly, anti-human IgM antibody did induce apoptosis in induction experiments. However, it was reversed by the addition of anti-CD40 antibody or BST cells, whereas the culture supernatant of the stroma cells did not show any effect on the inhibition of apoptosis. BALM-18 may be useful for analyzing both the mechanisms of anti-IgM induced apoptosis and signaling during the inhibition of apoptosis by CD40 or BST cells.

AB - A human acute lymphoblastic leukemia (ALL) cell line, BALM-18, was established from the peripheral blood specimen of a patient with B cell ALL L3 type (ALL-L3) at diagnosis using bone marrow stroma cells (BST) as feeder cells. The primary leukemia cells did not grow without feeder cells. As with the primary leukemia cells, BALM-18 showed an immunophenotype of Burkitt's lymphoma group I [CD10 +, CD20 +, CD23-, CD39-, CD77+] and carried the t(8;14)(q24;q32) chromosomal abnormality which is highly associated with ALL- L3 and Burkitt's lymphoma. It also revealed a significantly low level of bcl- 2 protein. Strikingly, anti-human IgM antibody did induce apoptosis in induction experiments. However, it was reversed by the addition of anti-CD40 antibody or BST cells, whereas the culture supernatant of the stroma cells did not show any effect on the inhibition of apoptosis. BALM-18 may be useful for analyzing both the mechanisms of anti-IgM induced apoptosis and signaling during the inhibition of apoptosis by CD40 or BST cells.

KW - ALL-L3

KW - Anti-IgM

KW - Apoptosis

KW - Bone marrow stroma cells

KW - CD40

KW - Cell line

UR - http://www.scopus.com/inward/record.url?scp=0032998622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032998622&partnerID=8YFLogxK

U2 - 10.1016/S0145-2126(99)00046-6

DO - 10.1016/S0145-2126(99)00046-6

M3 - Article

C2 - 10374849

AN - SCOPUS:0032998622

VL - 23

SP - 559

EP - 568

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 6

ER -